Additionally, promoter hypermethylation of the RIZ1 gene is prevalent in nasopharyngeal carcinoma, thereby playing a key role in clinical applications such as nasopharyngeal carcinoma screening and healing monitoring [66]. This evidence concerns the gene PRDM2 and nasopharyngeal carcinoma.